177 related articles for article (PubMed ID: 38370384)
1. Aldo-keto reductase 1B10 as a Carcinogenic but Not a Prognostic Factor in Colorectal Cancer.
Ye X; Wang T; Zhong L; Farrés J; Xia J; Zeng X; Cao D
J Cancer; 2024; 15(6):1657-1667. PubMed ID: 38370384
[TBL] [Abstract][Full Text] [Related]
2. Aldo-keto reductase 1B10 protects human colon cells from DNA damage induced by electrophilic carbonyl compounds.
Zu X; Yan R; Pan J; Zhong L; Cao Y; Ma J; Cai C; Huang D; Liu J; Chung FL; Liao DF; Cao D
Mol Carcinog; 2017 Jan; 56(1):118-129. PubMed ID: 26969882
[TBL] [Abstract][Full Text] [Related]
3. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
Yan R; Zu X; Ma J; Liu Z; Adeyanju M; Cao D
Int J Cancer; 2007 Nov; 121(10):2301-6. PubMed ID: 17597105
[TBL] [Abstract][Full Text] [Related]
4. High expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinoma.
Ha SY; Song DH; Lee JJ; Lee HW; Cho SY; Park CK
Gut Liver; 2014 Nov; 8(6):648-54. PubMed ID: 25287169
[TBL] [Abstract][Full Text] [Related]
5. Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).
Li H; Yang AL; Chung YT; Zhang W; Liao J; Yang GY
Carcinogenesis; 2013 Sep; 34(9):2090-8. PubMed ID: 23689354
[TBL] [Abstract][Full Text] [Related]
6. AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker.
Ma J; Luo DX; Huang C; Shen Y; Bu Y; Markwell S; Gao J; Liu J; Zu X; Cao Z; Gao Z; Lu F; Liao DF; Cao D
Int J Cancer; 2012 Sep; 131(6):E862-71. PubMed ID: 22539036
[TBL] [Abstract][Full Text] [Related]
7. Low expression of Aldo-keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma.
Guo Y; Luo W; Hu Z; Li J; Li X; Cao H; Li J; Wen B; Zhang J; Cheng H; Guo W; Tan T; Luo D
Cell Biosci; 2016; 6():18. PubMed ID: 26949513
[TBL] [Abstract][Full Text] [Related]
8. Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma.
Xie C; Ye X; Zeng L; Zeng X; Cao D
J Gastroenterol; 2023 Oct; 58(10):1030-1042. PubMed ID: 37500927
[TBL] [Abstract][Full Text] [Related]
9. Aldo-keto Reductase 1B10 Restrains Cell Migration, Invasion, and Adhesion of Gastric Cancer via Regulating Integrin Subunit Alpha 5.
Yao H; Hu J; Shao Y; Shah Q; Zheng S
Turk J Gastroenterol; 2023 Dec; 34(12):1197-1205. PubMed ID: 37823316
[TBL] [Abstract][Full Text] [Related]
10. Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice.
Shen Y; Ma J; Yan R; Ling H; Li X; Yang W; Gao J; Huang C; Bu Y; Cao Y; He Y; Wan L; Zu X; Liu J; Huang MC; Stenson WF; Liao DF; Cao D
Clin Cancer Res; 2015 Mar; 21(6):1466-76. PubMed ID: 25538260
[TBL] [Abstract][Full Text] [Related]
11. Compensatory upregulation of aldo-keto reductase 1B10 to protect hepatocytes against oxidative stress during hepatocarcinogenesis.
Liu Y; Zhang J; Liu H; Guan G; Zhang T; Wang L; Qi X; Zheng H; Chen CC; Liu J; Cao D; Lu F; Chen X
Am J Cancer Res; 2019; 9(12):2730-2748. PubMed ID: 31911858
[TBL] [Abstract][Full Text] [Related]
12. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.
Chung YT; Matkowskyj KA; Li H; Bai H; Zhang W; Tsao MS; Liao J; Yang GY
Mod Pathol; 2012 May; 25(5):758-66. PubMed ID: 22222635
[TBL] [Abstract][Full Text] [Related]
13. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.
Taskoparan B; Seza EG; Demirkol S; Tuncer S; Stefek M; Gure AO; Banerjee S
Cell Oncol (Dordr); 2017 Dec; 40(6):563-578. PubMed ID: 28929377
[TBL] [Abstract][Full Text] [Related]
14. AKR1B10 (Aldo-keto reductase family 1 B10) promotes brain metastasis of lung cancer cells in a multi-organ microfluidic chip model.
Liu W; Song J; Du X; Zhou Y; Li Y; Li R; Lyu L; He Y; Hao J; Ben J; Wang W; Shi H; Wang Q
Acta Biomater; 2019 Jun; 91():195-208. PubMed ID: 31034948
[TBL] [Abstract][Full Text] [Related]
15. Aldo-keto reductase 1B10 promotes development of cisplatin resistance in gastrointestinal cancer cells through down-regulating peroxisome proliferator-activated receptor-γ-dependent mechanism.
Matsunaga T; Suzuki A; Kezuka C; Okumura N; Iguchi K; Inoue I; Soda M; Endo S; El-Kabbani O; Hara A; Ikari A
Chem Biol Interact; 2016 Aug; 256():142-53. PubMed ID: 27417252
[TBL] [Abstract][Full Text] [Related]
16. Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway.
Yao Y; Wang X; Zhou D; Li H; Qian H; Zhang J; Jiang L; Wang B; Lin Q; Zhu X
Aging (Albany NY); 2020 Jul; 12(13):13059-13075. PubMed ID: 32615540
[TBL] [Abstract][Full Text] [Related]
17. AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway.
Huang C; Verhulst S; Shen Y; Bu Y; Cao Y; He Y; Wang Y; Huang D; Cai C; Rao K; Liao DF; Jin J; Cao D
Oncotarget; 2016 Jul; 7(28):43779-43791. PubMed ID: 27248472
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes.
Luo D; Bu Y; Ma J; Rajput S; He Y; Cai G; Liao DF; Cao D
J Biol Chem; 2013 Dec; 288(51):36733-40. PubMed ID: 24217247
[TBL] [Abstract][Full Text] [Related]
19. AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway.
Qu J; Li J; Zhang Y; He R; Liu X; Gong K; Duan L; Luo W; Hu Z; Wang G; Xia C; Luo D
Cell Biosci; 2021 Aug; 11(1):163. PubMed ID: 34419144
[TBL] [Abstract][Full Text] [Related]
20. AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study.
Cao Z; Delfino K; Tiwari V; Wang X; Hannan A; Zaidi F; McClintock A; Robinson K; Zhu Y; Gao J; Cao D; Rao K
Front Oncol; 2022; 12():727505. PubMed ID: 35280770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
